Prelude Capital Management’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,733
Closed -$488K 1271
2025
Q4
$488K Buy
+11,733
New +$476K 0.04% 547
2025
Q2
Sell
-4,473
Closed -$249K 1050
2025
Q1
$249K Buy
+4,473
New +$214K 0.02% 807
2023
Q3
Sell
-4,590
Closed -$371K 1162
2023
Q2
$371K Sell
4,590
-7,597
-62% -$710K 0.02% 577
2023
Q1
$1.48M Buy
12,187
+3,037
+33% +$412K 0.09% 257
2022
Q4
$1.22M Sell
9,150
-1,134
-11% -$138K 0.06% 316
2022
Q3
$1.15M Buy
10,284
+5,413
+111% +$693K 0.04% 383
2022
Q2
$661K Buy
4,871
+3,666
+304% +$552K 0.02% 677
2022
Q1
$201K Sell
1,205
-6,031
-83% -$1.15M 0.01% 1264
2021
Q4
$1.29M Sell
7,236
-20,893
-74% -$3.73M 0.03% 490
2021
Q3
$4.98M Sell
28,129
-8,719
-24% -$1.44M 0.13% 96
2021
Q2
$5.92M Sell
36,848
-13,582
-27% -$2.09M 0.18% 79
2021
Q1
$7.55M Buy
50,430
+9,470
+23% +$1.15M 0.19% 59
2020
Q4
$4.04M Buy
+40,960
New +$4.09M 0.1% 141

Other funds holding CNXC

Prelude Capital Management's CNXC Position: Q1 2026 in Review

Prelude Capital Management sold out of Concentrix (CNXC) in Q1 2026, closing a stake of 11,733 shares — an estimated $488K sold.

Prelude Capital Management first reported a position in CNXC in Q4 2020 and held it in 13 quarters. The position peaked at $7.55M in Q1 2021. 304 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Prelude Capital Management reported no remaining Concentrix position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 11,733 Concentrix shares in Q1 2026, an estimated $488K.
  • Prelude Capital Management first reported a position in Concentrix in Q4 2020 and held it in 13 quarters.
  • Prelude Capital Management's Concentrix position peaked at $7.55M in Q1 2021.
  • 304 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.